Theorem Clinical Research

Awards & Advancement

Discovery Labs adds to scientific leadership team

Friday, May 23, 2014 12:23 PM

Discovery Laboratories, a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, has strengthened its scientific leadership. Effective immediately, Steve Simonson, M.D., M.H.S., has joined the company as vice president, Clinical Development, and Lawrence Weinstein has joined as vice president, Medical Device Development.

More... »


Jack Modell joins Rho as senior medical officer

Thursday, May 22, 2014 11:15 AM

Rho, a privately held CRO located in Chapel Hill, N.C., has announced that Dr. Jack Modell joined its team as senior medical officer, bringing 20 years of experience in clinical research, teaching and patient care in academic medicine, and an additional 10 years of experience in clinical drug development (phase II-IV), medical affairs, medical governance, drug safety and management within the pharmaceutical industry. 

More... »


Human Longevity hires for clinical, regulatory/scientific and informatics

Thursday, May 22, 2014 10:43 AM

Human Longevity (HLI), a genomics and cell therapy-based diagnostic and therapeutic company, has announced three senior appointments to help build the company's business and technology platforms.

More... »

SAFE-BioPharma added to worldwide Adobe Approved Trust List

Friday, May 16, 2014 11:32 AM

Adobe has added SAFE-BioPharma to its Adobe Approved Trust List (AATL). Effective immediately, anyone with a SAFE-BioPharma identity credential will be able to sign a PDF document in Adobe Acrobat, or Reader that will be automatically trusted globally by any other user of Adobe Acrobat, or Reader.

More... »

Kinex Pharmaceuticals appoints two to New Jersey clinical office

Wednesday, May 14, 2014 03:22 PM

Kinex Pharmaceuticals has announced the addition of two key executives to its clinical leadership team reporting to chief medical officer, Dr. Rudolf Kwan. Douglas Kramer, M.D., joins Kinex as vice president of Clinical and Regulatory Affairs and Jane Devane has joined Kinex as director of Clinical Operations.

More... »

Coherus Biosciences appoints Lisa M. Bell senior VP, Global Regulatory Affairs

Monday, May 12, 2014 12:41 PM

Coherus Biosciences, a biologics platform company delivering biosimilar therapeutics, has appointed Lisa M. Bell, Ph.D. senior vice president, Global Regulatory Affairs. Bell joins Coherus with more than 15 years of experience in global regulatory affairs and drug development across various therapeutic areas at preeminent biotech companies.

More... »

Auspex Pharmaceuticals appoints Lynn Bleil, Scott Greer to board of directors

Friday, May 9, 2014 12:53 PM

Auspex Pharmaceuticals, a late clinical stage biopharmaceutical company focused on developing and commercializing novel medicines for the treatment of orphan diseases, has announced the expansion of its board of directors with the appointment of two new members: Lynn D. Bleil, former leader of McKinsey & Company's West Coast Healthcare Practice and a leader of the worldwide Healthcare Practice; and R. Scott Greer, managing director of Numenor Ventures, and former founder, chairman and CEO of Abgenix. The total number of Auspex board members is increased to nine.

More... »

Rolf Stahel joins board of Ergomed as non-executive chairman

Thursday, May 8, 2014 02:08 PM

Ergomed, a U.K.-based drug development and services company, has appointed Rolf Stahel to its board as non-executive chairman.

More... »

DAC Patient Recruitment Services claims two Hermes Creative Awards

Wednesday, May 7, 2014 02:49 PM

DAC Patient Recruitment Services, an Imperial company and provider of patient recruitment and retention for global clinical trials, earned two international Hermes Creative Awards  for writing and design this year, including a Gold Award and the highest Hermes honor—the Platinum Award.

More... »

Kapil Dhingra joins Advanced Accelerator Applications board of directors

Friday, May 2, 2014 11:13 AM

Advanced Accelerator Applications (AAA), an international specialist in molecular nuclear medicine, has announced that Dr. Kapil Dhingra has joined the company board of directors as an independent non-executive director.

More... »

Subscribe to The CenterWatch Monthly
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 2

Roche's $8.3B InterMune buy continues its buying spree with 'bolt-on' deal, fueling record M&A activity

FDA action plan seeks to close gap in women and minority patient representation in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs